120 related articles for article (PubMed ID: 3143491)
1. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients].
Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
De Groof D; Bruneel H; Musumari TS; Ruppol JF
Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
[TBL] [Abstract][Full Text] [Related]
3. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense].
Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ
Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607
[TBL] [Abstract][Full Text] [Related]
4. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
Milord F; Pépin J; Loko L; Ethier L; Mpia B
Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
[TBL] [Abstract][Full Text] [Related]
6. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
7. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
8. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire.
Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K
Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607
[TBL] [Abstract][Full Text] [Related]
9. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
Na-Bangchang K; Doua F; Konsil J; Hanpitakpong W; Kamanikom B; Kuzoe F
Eur J Clin Pharmacol; 2004 Jun; 60(4):269-78. PubMed ID: 15141331
[TBL] [Abstract][Full Text] [Related]
11. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
Milord F; Loko L; Ethier L; Mpia B; Pépin J
Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
[TBL] [Abstract][Full Text] [Related]
12. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)].
Hamon JF; Camara P
Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798
[TBL] [Abstract][Full Text] [Related]
13. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.
Van Nieuwenhove S; Schechter PJ; Declercq J; Boné G; Burke J; Sjoerdsma A
Trans R Soc Trop Med Hyg; 1985; 79(5):692-8. PubMed ID: 3938090
[TBL] [Abstract][Full Text] [Related]
14. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients.
Taelman H; Schechter PJ; Marcelis L; Sonnet J; Kazyumba G; Dasnoy J; Haegele KD; Sjoerdsma A; Wery M
Am J Med; 1987 Mar; 82(3 Spec No):607-14. PubMed ID: 3103442
[TBL] [Abstract][Full Text] [Related]
15. [A new molecule in antiparasitic therapy: alpha-difluoromethylornithine].
Furet Y; Duong TH; Combescot C; Breteau M
Pathol Biol (Paris); 1987 Apr; 35(4):398-404. PubMed ID: 3108836
[TBL] [Abstract][Full Text] [Related]
16. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
Pepin J; Milord F; Guern C; Schechter PJ
Lancet; 1987 Dec; 2(8573):1431-3. PubMed ID: 2891995
[TBL] [Abstract][Full Text] [Related]
17. Eflornithine for the treatment of human African trypanosomiasis.
Burri C; Brun R
Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
[TBL] [Abstract][Full Text] [Related]
18. Advances in sleeping sickness therapy.
Van Nieuwenhove S
Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
[TBL] [Abstract][Full Text] [Related]
19. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.
Jansson-Löfmark R; Na-Bangchang K; Björkman S; Doua F; Ashton M
Antimicrob Agents Chemother; 2015 Feb; 59(2):1299-307. PubMed ID: 25512417
[TBL] [Abstract][Full Text] [Related]
20. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
